Sotuvning operatsion marjasi: Werewolf (HOWL)

Werewolf Therapeutics Inc. (HOWL) kompaniyasining korporativ logotipi

Werewolf Therapeutics (HOWL) iqtisodiy sikllardan mustaqildir, chunki uning muvaffaqiyati ilmiy progress bilan bog'liq. Operatsion marja ko'rsatkichlari asosiy faoliyatdan olingan foyda dinamikasini aks ettiradi, bunda -90.90 ushbu metrikaning joriy darajasini ifodalaydi. Himoyalangan intellektual mulk uzoq muddatli sherikliklar uchun asos yaratadi. Kapitalizatsiyaning asosiy drayveri yangi immuno-onkologiya molekulalarining erta bosqichdagi sinovlari natijalari bo'lib qolmoqda.

HOWL: Werewolf Therapeutics Inc. Operatsion foyda normasi 04.07.2022 - 19.11.2026

Werewolf Therapeutics Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (HOWL)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:HOWL, werewolftx.com
Werewolf Therapeutics, Inc. asosiy tovari

Werewolf Therapeutics (HOWL) kompaniyasining fundamental baholanishi dori vositalarining toksikligini minimallashtiruvchi proprietary PREDATOR texnologiyasining tijoratlashtirish samaradorligini tahlil qilishni talab etadi. Tarixiy operatsion marjalarni o'rganish orqali investor asosiy operatsion foydaning tushumga nisbatini aniqlashi mumkin, bu esa marja ko'rsatkichlari cho'qqisiga chiqqan vaqtda aktiv uchun haddan tashqari ko'p to'lov qilishdan qochish uchun qarz va soliq majburiyatlarigacha bo'lgan biznes daromadliligini baholash imkonini beradi.

Werewolf Therapeutics kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Compass Therapeutics - Operatsion foyda normasi|REPL (replimune.com) - Operatsion marja|Operatsion marja Lyell|Operatsion rentabellik Innate Pharma (IPHA)|PYXS: Operatsion foyda marjasi|Compugen - Sotuvning operatsion marjasi|IO Biotech, Inc. (IOBT) - Sotuvning operatsion rentabelligi|STRO - Operatsion rentabellik|MiNK Therapeutics (INKT) - Sotuvning operatsion marjasi|Immix (IMMX) - Operatsion rentabellik|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja